Pharmaceutical Composition for Gynecological Diseases in Specialized Environments
Legal Citation
Summary of the Inventive Concept
A novel pharmaceutical composition and system for preventing or treating gynecological diseases in extreme weather conditions, high-security environments, disaster relief scenarios, and areas with limited access to medical facilities, utilizing Sarcodon aspratus extracts as active ingredients.
Background and Problem Solved
The original patent disclosed a pharmaceutical composition for preventing or treating gynecological diseases using Sarcodon aspratus extracts. However, this composition may not be suitable for use in extreme weather conditions, high-security environments, disaster relief scenarios, or areas with limited access to medical facilities. The present inventive concept addresses these limitations by adapting the composition and system for these specialized environments.
Detailed Description of the Inventive Concept
The inventive concept comprises a portable pharmaceutical composition dispenser adapted to dispense a pharmaceutical composition containing Sarcodon aspratus extracts as active ingredients, designed to operate in temperatures ranging from -20°C to 40°C. Additionally, the composition can be formulated to be undetectable by security screening devices for use in high-security environments. In disaster relief scenarios, the kit comprises a pharmaceutical composition, a water purification system, and a portable heating device. The composition can also be formulated to have a prolonged shelf life and packaged in a compact, lightweight container for use in areas with limited access to medical facilities. Furthermore, a system for remote monitoring and treatment of gynecological diseases can be implemented, comprising a wearable device, a communication module, and a pharmaceutical composition dispenser, designed to operate in areas with limited internet connectivity.
Novelty and Inventive Step
The inventive concept's novelty lies in its adaptation of the original pharmaceutical composition for use in specialized environments, such as extreme weather conditions, high-security environments, disaster relief scenarios, and areas with limited access to medical facilities. The inventive step is the integration of the composition with novel dispensing systems, formulations, and packaging designs that enable its effective use in these environments.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include variations in the dispenser design, such as solar-powered or hand-cranked dispensers, or the use of different active ingredients in combination with Sarcodon aspratus extracts. Additionally, the system for remote monitoring and treatment could be implemented using different communication protocols or wearable devices.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the pharmaceutical industry, particularly in the areas of disaster relief, high-security environments, and remote healthcare. The target market includes government agencies, non-governmental organizations, and private companies operating in these specialized environments.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K36/07 |
| A | A61 | A61K9/0056 |
| A | A61 | A61P15/08 |
| A | A61 | A61K2236/333 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Pharmaceutical compositions for women's health, specifically gynecological disease treatment, with expertise in botanical extracts, pharmaceutical formulation, and medical device design
Person of Ordinary Skill (PHOSITA) Profile
A professional with advanced degrees in pharmacy, biotechnology, or medical engineering, having knowledge of herbal medicine, pharmaceutical delivery systems, and adaptive medical technologies for specialized environments
Obviousness Rationale
A PHOSITA would recognize that extending the Sarcodon aspratus extract composition to specialized environmental contexts represents a predictable application of known pharmaceutical principles. The core therapeutic mechanism remains consistent with the source patent, while the variations address practical implementation challenges in different operational contexts. These adaptations demonstrate standard engineering problem-solving approaches typical in medical technology development.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,586 |
|---|---|
| Title | Pharmaceutical composition for preventing or treating gynecological diseases containing Sarcodon aspratus extracts as active ingredient |